ArticleVaccines2022

Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA Vaccine.

Mohammad Said Ashenagar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.